Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 833

1.

Surfactant-replacement therapy for respiratory distress in the preterm and term neonate.

Engle WA; American Academy of Pediatrics Committee on Fetus and Newborn.

Pediatrics. 2008 Feb;121(2):419-32. doi: 10.1542/peds.2007-3283.

PMID:
18245434
2.

Surfactant replacement therapy for preterm and term neonates with respiratory distress.

Polin RA, Carlo WA; Committee on Fetus and Newborn; American Academy of Pediatrics.

Pediatrics. 2014 Jan;133(1):156-63. doi: 10.1542/peds.2013-3443. Epub 2013 Dec 30.

3.

Surfactant use for neonatal lung injury: beyond respiratory distress syndrome.

Finer NN.

Paediatr Respir Rev. 2004;5 Suppl A:S289-97. Review.

PMID:
14980286
5.

Use of surfactant in pulmonary disorders in full-term infants.

Sun B.

Curr Opin Pediatr. 1996 Apr;8(2):113-7. Review.

PMID:
8723804
6.

[Secondary surfactant deficiencies].

Escande B, Kuhn P, Rivera S, Messer J.

Arch Pediatr. 2004 Nov;11(11):1351-9. Review. French.

PMID:
15519836
7.
8.

Surfactant in the preterm infant: what's going on.

Dani C, Barp J, Berti E, Bertini G.

J Matern Fetal Neonatal Med. 2009;22 Suppl 3:3-5. doi: 10.1080/14767050903198355. Review.

PMID:
19925357
9.

[Surfactant treatment of acute pulmonary failure. Other indications than neonatal distress syndrome].

Silberg IE, Grønn M.

Tidsskr Nor Laegeforen. 1997 Apr 20;117(10):1456-8. Norwegian.

PMID:
9198922
10.

Pulmonary surfactant for neonatal respiratory disorders.

Merrill JD, Ballard RA.

Curr Opin Pediatr. 2003 Apr;15(2):149-54. Review.

PMID:
12640270
11.

Respiratory support in preterm infants at birth.

Committee on Fetus and Newborn; American Academy of Pediatrics.

Pediatrics. 2014 Jan;133(1):171-4. doi: 10.1542/peds.2013-3442. Epub 2013 Dec 30.

12.

Surfactant therapy in full-term neonates with severe respiratory failure.

Khammash H, Perlman M, Wojtulewicz J, Dunn M.

Pediatrics. 1993 Jul;92(1):135-9.

PMID:
8516059
13.

Surfactant replacement therapy. An update on applications.

Dekowski SA, Holtzman RB.

Pediatr Clin North Am. 1998 Jun;45(3):549-72. Review.

PMID:
9653436
14.

The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.

Dargaville PA, Kamlin CO, De Paoli AG, Carlin JB, Orsini F, Soll RF, Davis PG.

BMC Pediatr. 2014 Aug 27;14:213. doi: 10.1186/1471-2431-14-213.

15.

The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.

Wirbelauer J, Speer CP.

J Perinatol. 2009 May;29 Suppl 2:S18-22. doi: 10.1038/jp.2009.30. Review.

PMID:
19399004
16.

Exogenous surfactant therapy in newborns.

Rodriguez RJ, Martin RJ.

Respir Care Clin N Am. 1999 Dec;5(4):595-616. Review.

PMID:
10565883
18.

Surfactant treatment of neonates with respiratory failure and group B streptococcal infection. Members of the Collaborative European Multicenter Study Group.

Herting E, Gefeller O, Land M, van Sonderen L, Harms K, Robertson B.

Pediatrics. 2000 Nov;106(5):957-64; discussion 1135.

PMID:
11061760
19.

Management of respiratory distress syndrome: an update.

Rodriguez RJ.

Respir Care. 2003 Mar;48(3):279-86; discussion 286-7. Review.

20.

Neonatal acute respiratory failure.

Gnanaratnem J, Finer NN.

Curr Opin Pediatr. 2000 Jun;12(3):227-32. Review.

PMID:
10836158
Items per page

Supplemental Content

Write to the Help Desk